EOLS FY 2016 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$326,000

Operating Income

-$20M

Net Income

-$20M

EPS (Diluted)

$-1.08

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$957,000

Balance Sheet

Total Assets

$77M

Total Liabilities

$85M

Stockholders' Equity

-$7M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$326,000	-$416,000	+21.6%
Operating Income	-$20M	-$31M	+35.6%
Net Income	-$20M	-$31M	+35.5%